Page last updated: 2024-10-31

methoxsalen and Graft-Versus-Host Disease

methoxsalen has been researched along with Graft-Versus-Host Disease in 29 studies

Methoxsalen: A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.
methoxsalen : A member of the class of psoralens that is 7H-furo[3,2-g]chromen-7-one in which the 9 position is substituted by a methoxy group. It is a constituent of the fruits of Ammi majus. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered topically or orally in conjunction with UV-A for phototherapy treatment of vitiligo and severe psoriasis.

Research Excerpts

ExcerptRelevanceReference
" In serum, peak 8-MOP concentrations were reached < or =40 min following ingestion; the half-life of 8-MOP in the serum was 50+/-14 min (n=7)."1.30Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis. ( Nestle, FO; Panizzon, R; Shephard, SE, 1999)
"A 45-year-old male with chronic myelocytic leukemia who received a bone marrow transplantation from a phenotypically HLA-matched unrelated donor developed chronic GVHD on day 100 post transplantation."1.29A case of chronic GVHD following bone marrow transplantation from a phenotypically HLA-matched unrelated donor. ( Sano, Y; Shimao, S; Tanaka, K, 1994)

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.45)18.7374
1990's6 (20.69)18.2507
2000's5 (17.24)29.6817
2010's13 (44.83)24.3611
2020's4 (13.79)2.80

Authors

AuthorsStudies
Buder, K2
Zirngibl, M2
Bapistella, S2
Meerpohl, JJ2
Strahm, B2
Bassler, D2
Weitz, M2
Alsuliman, T1
Magro, L1
Coiteux, V1
Gauthier, J1
Srour, M1
Lionet, A1
Beauvais, D1
Yakoub-Agha, I1
Hähnel, V1
Brosig, AM1
Ehrenschwender, M1
Burkhardt, R1
Offner, R1
Ahrens, N1
Holien, T1
Gederaas, OA1
Darvekar, SR1
Christensen, E1
Peng, Q1
Budde, H1
Papert, S1
Reichardt, HM1
Jarry, H1
Riggert, J1
Legler, TJ1
Coppard, C1
Hannani, D1
Humbert, M1
Gauthier, V1
Plumas, J1
Merlin, E1
Gabert, F1
Chaperot, L1
Jagasia, M1
Scheid, C1
Socié, G1
Ayuk, FA1
Tischer, J1
Donato, ML1
Bátai, Á1
Chen, H1
Chen, SC1
Chin, T1
Boodée, H1
Mitri, G1
Greinix, HT2
Bojanic, I1
Serventi Seiwerth, R1
Golubic Cepulic, B1
Mazic, S1
Lukic, M1
Raos, M1
Plenkovic, F1
Golemovic, M1
Dubravcic, K1
Perkovic, S1
Batinic, D1
Labar, B1
Heshmati, F2
Taverna, F1
Coluccia, P1
Arienti, F1
Birolini, A1
Terranova, L1
Mazzocchi, A1
Rini, F1
Mariani, L1
Melani, C1
Ravagnani, F1
Feldreich, N1
Ringden, O1
Emtestam, L1
Omazic, B1
Di Biaso, I1
Di Maio, L1
Bugarin, C1
Gaipa, G1
Dander, E1
Balduzzi, A1
Parma, M1
D'Amico, G1
Perseghin, P1
Biondi, A1
Biagi, E1
Perotti, C1
Del Fante, C1
Tinelli, C1
Viarengo, G1
Scudeller, L1
Zecca, M1
Locatelli, F1
Salvaneschi, L1
Capitini, CM1
Davis, JP1
Larabee, SM1
Herby, S1
Nasholm, NM1
Fry, TJ1
Kofoed, K1
Schiødt, I1
Gniadecki, R1
Daniele, N1
Del Proposto, G1
Cerrone, P1
Sinopoli, S1
Sansone, L1
Gadaleta, DI1
Lanti, A1
Ferraro, AS1
Spurio, S1
Scerpa, MC1
Zinno, F1
Adorno, G1
Isacchi, G1
Trautinger, F1
Just, U1
Knobler, R1
Mabed, M1
Coffe, C1
Racadot, E1
Angonin, R1
Pavey, JJ1
Tiberghien, P1
Herve, P1
Peritt, D1
Sano, Y1
Tanaka, K1
Shimao, S1
Grass, JA1
Hei, DJ1
Metchette, K1
Cimino, GD1
Wiesehahn, GP1
Corash, L1
Lin, L1
Nishimura, M1
Akaza, T1
Tadokoro, K1
Juji, T1
Zic, JA1
Miller, JL1
Stricklin, GP1
King, LE1
Shephard, SE1
Nestle, FO1
Panizzon, R1
Volc-Platzer, B1
Kalhs, P1
Fischer, G1
Rosenmayr, A1
Keil, F1
Hönigsmann, H1
Knobler, RM1
Eppinger, T1
Ehninger, G2
Steinert, M2
Niethammer, D1
Dopfer, R2
Jaschonek, K1
Einsele, H1
Schmidt, H1
Lenz, HJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy With UVADEX for the Treatment of Patients With Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)[NCT01380535]Early Phase 160 participants (Actual)Interventional2011-11-30Completed
Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients[NCT04414735]30 participants (Anticipated)Interventional2022-08-17Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With an Overall Response at Week 28

Participants with overall response included those with partial response or complete response, according to study staff who did not know which treatment they received (blinded assessment). (NCT01380535)
Timeframe: Week 28

InterventionParticipants (Count of Participants)
ECP Methoxsalen + SoC20
Standard of Care (SoC)14

Reviews

8 reviews available for methoxsalen and Graft-Versus-Host Disease

ArticleYear
Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    The Cochrane database of systematic reviews, 2022, 06-09, Volume: 6

    Topics: Adolescent; Child; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation;

2022
Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    The Cochrane database of systematic reviews, 2022, 09-27, Volume: 9

    Topics: Adolescent; Adrenal Cortex Hormones; Child; Graft vs Host Disease; Hematopoietic Stem Cell Transplan

2022
Updating ECP action mechanisms.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2014, Volume: 50, Issue:3

    Topics: Apoptosis; Dendritic Cells; Graft Rejection; Graft vs Host Disease; Humans; Immunity, Cellular; Inte

2014
[Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
    Ugeskrift for laeger, 2011, Jun-27, Volume: 173, Issue:26

    Topics: Evidence-Based Medicine; Graft vs Host Disease; Humans; Lymphoma, T-Cell, Cutaneous; Methoxsalen; Ph

2011
Photopheresis (extracorporeal photochemotherapy).
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2013, Volume: 12, Issue:1

    Topics: Graft Rejection; Graft vs Host Disease; Humans; Lymphoma, T-Cell, Cutaneous; Methoxsalen; Photophere

2013
Mechanisms of action of extracorporeal photochemotherapy.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2003, Volume: 29, Issue:1

    Topics: Apoptosis; CD4-Positive T-Lymphocytes; CD40 Antigens; CD8-Positive T-Lymphocytes; Cell Membrane; Cro

2003
Potential mechanisms of photopheresis in hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:1 Suppl 2

    Topics: Antigen Presentation; Antigen-Presenting Cells; Apoptosis; CD8-Positive T-Lymphocytes; Cytokines; Gr

2006
The North American experience with photopheresis.
    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 1999, Volume: 3, Issue:1

    Topics: Arthritis, Rheumatoid; Graft vs Host Disease; Humans; Lymphoma, T-Cell, Cutaneous; Methoxsalen; Nort

1999

Trials

4 trials available for methoxsalen and Graft-Versus-Host Disease

ArticleYear
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD.
    Blood advances, 2019, 07-23, Volume: 3, Issue:14

    Topics: Adult; Aged; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; M

2019
Treatment of chronic GVHD with extracorporeal photochemotherapy.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2013, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Female; Graft vs Host Disease; Humans; Leukapheresi

2013
Evaluation of cell death after treatment with extracorporeal photopheresis.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2012, Volume: 46, Issue:1

    Topics: Adult; Apoptosis; Female; Graft vs Host Disease; Humans; Leukocytes; Male; Methoxsalen; Middle Aged;

2012
Potential usefulness of photochemotherapy using 8-methoxypsoralen in the treatment of posttransfusion graft-versus-host disease.
    Vox sanguinis, 1998, Volume: 75, Issue:4

    Topics: Graft vs Host Disease; Humans; Japan; Methoxsalen; Photochemotherapy; Photosensitizing Agents; Trans

1998

Other Studies

17 other studies available for methoxsalen and Graft-Versus-Host Disease

ArticleYear
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
    Current research in translational medicine, 2020, Volume: 68, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Chronic Disease; Combined Modality Therapy; Drug Resistance; Female;

2020
Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
    Transfusion, 2021, Volume: 61, Issue:10

    Topics: Adult; Aged; Apoptosis; Female; Graft vs Host Disease; Humans; Lymphocytes; Male; Methoxsalen; Middl

2021
Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
    Lasers in surgery and medicine, 2018, Volume: 50, Issue:5

    Topics: Aminolevulinic Acid; Cell Culture Techniques; Graft vs Host Disease; Humans; Lymphoma, T-Cell, Cutan

2018
An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
    Vox sanguinis, 2018, Volume: 113, Issue:8

    Topics: Allogeneic Cells; Animals; Graft vs Host Disease; Humans; Leukocytes; Male; Methoxsalen; Mice; Mice,

2018
In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.
    Journal of clinical apheresis, 2019, Volume: 34, Issue:4

    Topics: Apoptosis; Calreticulin; Cells, Cultured; Dendritic Cells; Graft vs Host Disease; HMGB1 Protein; Hum

2019
Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
    Journal of clinical apheresis, 2015, Volume: 30, Issue:3

    Topics: Adult; Aged; Apoptosis; Blood Component Removal; Cell Proliferation; Cell Separation; Female; Flow C

2015
Photochemotherapy of Cutaneous Graft-versus-Host Disease May Reduce Concomitant Visceral Disease.
    Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:4

    Topics: Adolescent; Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Stud

2016
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells.
    Transplantation, 2009, May-15, Volume: 87, Issue:9

    Topics: Graft vs Host Disease; Humans; Inflammation; Methoxsalen; Photopheresis; T-Lymphocytes; T-Lymphocyte

2009
Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
    Transfusion, 2010, Volume: 50, Issue:6

    Topics: Acute Disease; Adolescent; Child; Child, Preschool; Chronic Disease; Disease-Free Survival; Female;

2010
Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:6

    Topics: Animals; Bone Marrow Transplantation; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniq

2011
Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
    Annals of hematology, 2006, Volume: 85, Issue:1

    Topics: Animals; Bone Marrow Transplantation; Cells, Cultured; Dose-Response Relationship, Radiation; Graft

2006
A case of chronic GVHD following bone marrow transplantation from a phenotypically HLA-matched unrelated donor.
    The Journal of dermatology, 1994, Volume: 21, Issue:4

    Topics: Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Histocompatibility; Humans; Leu

1994
Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
    Blood, 1998, Mar-15, Volume: 91, Issue:6

    Topics: Adult; DNA Adducts; DNA Damage; Gamma Rays; Graft vs Host Disease; Humans; Interleukin-8; Leukocyte

1998
Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
    Photodermatology, photoimmunology & photomedicine, 1999, Volume: 15, Issue:2

    Topics: Adult; Aged; Biological Availability; Chromatography, High Pressure Liquid; Dose-Response Relationsh

1999
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.
    Blood, 2000, Oct-01, Volume: 96, Issue:7

    Topics: Acute Disease; Adult; Biopsy; Drug Resistance; Female; Gastrointestinal Hemorrhage; Graft vs Host Di

2000
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
    Transplantation, 1990, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; Humans; Male;

1990
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
    Lancet (London, England), 1988, Mar-12, Volume: 1, Issue:8585

    Topics: Graft vs Host Disease; Humans; Methoxsalen; PUVA Therapy; Skin Diseases

1988